These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 17963824)

  • 1. pRB detection as a common event in human retinoblastomas: an immunohistochemical study.
    Rodríguez-Cruz M; Sanchez R; Arenas D; Coral-Vazquez R; Velazquez AC; Ramón-García G; Siordia G; Salamanca F; Salcedo M
    Acta Histochem; 2008; 110(2):109-16. PubMed ID: 17963824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastoma.
    Orjuela M; Orlow I; Dudas M; Ponce-Castañeda MV; Ridaura C; Leal C; Salazar A; Abramson D; Gerald W; Cordon-Cardo C
    Hum Pathol; 2001 May; 32(5):537-44. PubMed ID: 11381373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Missing expression of pRb2/p130 in human retinoblastomas is associated with reduced apoptosis and lesser differentiation.
    Bellan C; De Falco G; Tosi GM; Lazzi S; Ferrari F; Morbini G; Bartolomei S; Toti P; Mangiavacchi P; Cevenini G; Trimarchi C; Cinti C; Giordano A; Leoncini L; Tosi P; Cottier H
    Invest Ophthalmol Vis Sci; 2002 Dec; 43(12):3602-8. PubMed ID: 12454024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity and mutations are the major mechanisms of RB1 gene inactivation in Chinese with sporadic retinoblastoma.
    Choy KW; Pang CP; Yu CB; Wong HL; Ng JS; Fan DS; Lo KW; Chai JT; Wang J; Fu W; Lam DS
    Hum Mutat; 2002 Nov; 20(5):408. PubMed ID: 12402348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutional genomic instability, chromosome aberrations in tumor cells and retinoblastoma.
    Amare Kadam PS; Ghule P; Jose J; Bamne M; Kurkure P; Banavali S; Sarin R; Advani S
    Cancer Genet Cytogenet; 2004 Apr; 150(1):33-43. PubMed ID: 15041221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathological features and P-glycoprotein expression in retinoblastoma.
    Filho JP; Correa ZM; Odashiro AN; Coutinho AB; Martins MC; Erwenne CM; Burnier MN
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3478-83. PubMed ID: 16186322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of overexpression of HMGA1 and HMGA2 with poor tumor differentiation, invasion, and proliferation associated with let-7 down-regulation in retinoblastomas.
    Mu G; Liu H; Zhou F; Xu X; Jiang H; Wang Y; Qu Y
    Hum Pathol; 2010 Apr; 41(4):493-502. PubMed ID: 20004941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unilateral retinoblastoma, lack of familial history and older age does not exclude germline RB1 gene mutation.
    Brichard B; Heusterspreute M; De Potter P; Chantrain C; Vermylen C; Sibille C; Gala JL
    Eur J Cancer; 2006 Jan; 42(1):65-72. PubMed ID: 16343894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between telomerase activity and basic fibroblast growth factor up-regulation in retinoblastomas.
    Kondo Y; Tanaka Y; Shields JA; Kondo S
    Anticancer Res; 2001; 21(6A):3765-72. PubMed ID: 11911245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological and histological study on retinoblastoma.
    Fujisawa K; Itoh K; Imai Y; Itoh H; Yamamoto M
    Kobe J Med Sci; 1998 Feb; 44(1):19-30. PubMed ID: 9846055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative genomic hybridization of 49 primary retinoblastoma tumors identifies chromosomal regions associated with histopathology, progression, and patient outcome.
    Lillington DM; Kingston JE; Coen PG; Price E; Hungerford J; Domizio P; Young BD; Onadim Z
    Genes Chromosomes Cancer; 2003 Feb; 36(2):121-8. PubMed ID: 12508240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress in retinoblastoma: correlations with clinicopathologic features and tumor invasiveness.
    Deepa PR; Nalini V; Mallikarjuna K; Vandhana S; Krishnakumar S
    Curr Eye Res; 2009 Dec; 34(12):1011-8. PubMed ID: 19958119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The study on the correlation between telomerase and histopathologic features of retinoblastoma].
    Ren RJ; Li B; Sun XL; Zheng BH; Li LQ; Chen CX
    Zhonghua Yan Ke Za Zhi; 2004 Apr; 40(4):234-8. PubMed ID: 15268829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive multistep clinical molecular screening of 180 unrelated individuals with retinoblastoma detects 36 novel mutations in the RB1 gene.
    Nichols KE; Houseknecht MD; Godmilow L; Bunin G; Shields C; Meadows A; Ganguly A
    Hum Mutat; 2005 Jun; 25(6):566-74. PubMed ID: 15884040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten novel RB1 gene mutations in patients with retinoblastoma.
    Abouzeid H; Munier FL; Thonney F; Schorderet DF
    Mol Vis; 2007 Sep; 13():1740-5. PubMed ID: 17960112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genomic retinoblastoma perspectives: implications of tumor supressor gene RB1].
    Rodríguez-Cruz M; del Prado M; Salcedo M
    Rev Invest Clin; 2005; 57(4):572-81. PubMed ID: 16315642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microarray analysis and biochemical correlations of oxidative stress responsive genes in retinoblastoma.
    Vandhana S; Lakshmi TS; Indra D; Deepa PR; Krishnakumar S
    Curr Eye Res; 2012 Sep; 37(9):830-41. PubMed ID: 22668346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of p75 neurotrophin receptor expression accompanies malignant progression to human and murine retinoblastoma.
    Dimaras H; Coburn B; Pajovic S; Gallie BL
    Mol Carcinog; 2006 May; 45(5):333-43. PubMed ID: 16555252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 gene gets altered by various mechanisms: studies in childhood sarcomas and retinoblastoma.
    Ghule P; Kadam PA; Jambhekar N; Bamne M; Pai S; Nair C; Banavali S; Puri A; Agarwal M
    Med Sci Monit; 2006 Dec; 12(12):BR385-396. PubMed ID: 17136003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for RB1 mutations in tumor tissue using denaturing high performance liquid chromatography, multiplex ligation-dependent probe amplification, and loss of heterozygosity analysis.
    Sellner LN; Edkins E; Smith N
    Pediatr Dev Pathol; 2006; 9(1):31-7. PubMed ID: 16808635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.